Mononuclear Cell Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT03352310
Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 16, 2018
Completion: Dec 30, 2020
Loading map...